These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
210 related articles for article (PubMed ID: 1681462)
1. The effect of L-dopa and carbidopa treatment on the survival of rat fetal dopamine grafts assessed by tyrosine hydroxylase immunohistochemistry and [3H]mazindol autoradiography. Blunt SB; Jenner P; Marsden CD Neuroscience; 1991; 43(1):95-110. PubMed ID: 1681462 [TBL] [Abstract][Full Text] [Related]
2. Motor function, graft survival and gliosis in rats with 6-OHDA lesions and foetal ventral mesencephalic grafts chronically treated with L-dopa and carbidopa. Blunt SB; Jenner P; Marsden CD Exp Brain Res; 1992; 88(2):326-40. PubMed ID: 1577107 [TBL] [Abstract][Full Text] [Related]
3. The effect of chronic L-dopa treatment on the recovery of motor function in 6-hydroxydopamine-lesioned rats receiving ventral mesencephalic grafts. Blunt S; Jenner P; Marsden CD Neuroscience; 1991; 40(2):453-64. PubMed ID: 1902916 [TBL] [Abstract][Full Text] [Related]
4. Autoradiographic study of striatal dopamine re-uptake sites and dopamine D1 and D2 receptors in a 6-hydroxydopamine and quinolinic acid double-lesion rat model of striatonigral degeneration (multiple system atrophy) and effects of embryonic ventral mesencephalic, striatal or co-grafts. Puschban Z; Scherfler C; Granata R; Laboyrie P; Quinn NP; Jenner P; Poewe W; Wenning GK Neuroscience; 2000; 95(2):377-88. PubMed ID: 10658617 [TBL] [Abstract][Full Text] [Related]
5. Autoradiographic study of striatal D1 and D2 dopamine receptors in 6-OHDA-lesioned rats receiving foetal ventral mesencephalic grafts and chronic treatment with L-dopa and carbidopa. Blunt SB; Jenner P; Marsden CD Brain Res; 1992 Jun; 582(2):299-311. PubMed ID: 1393551 [TBL] [Abstract][Full Text] [Related]
6. Dopaminergic transplants normalize amphetamine- and apomorphine-induced Fos expression in the 6-hydroxydopamine-lesioned striatum. Cenci MA; Kalén P; Mandel RJ; Wictorin K; Björklund A Neuroscience; 1992; 46(4):943-57. PubMed ID: 1347413 [TBL] [Abstract][Full Text] [Related]
7. A 6-hydroxydopamine-induced selective parkinsonian rat model: further biochemical and behavioral characterization. Thomas J; Wang J; Takubo H; Sheng J; de Jesus S; Bankiewicz KS Exp Neurol; 1994 Apr; 126(2):159-67. PubMed ID: 7925817 [TBL] [Abstract][Full Text] [Related]
8. Early and widespread normalization of dopamine-neuropeptide Y interactions in the rat striatum after transplantation of fetal mesencephalon cells. Moukhles H; Nieoullon A; Daszuta A Neuroscience; 1992; 47(4):781-92. PubMed ID: 1349734 [TBL] [Abstract][Full Text] [Related]
9. The effect of L-dopa and carbidopa on behavioural recovery produced by ventral mesencephalic grafts in rats. Blunt SB; Jenner P; Marsden CD Prog Brain Res; 1990; 82():493-8. PubMed ID: 2127116 [No Abstract] [Full Text] [Related]
10. Fetal intra-nigral ventral mesencephalon and kidney tissue bridge transplantation restores the nigrostriatal dopamine pathway in hemi-parkinsonian rats. Chiang Y; Morales M; Zhou FC; Borlongan C; Hoffer BJ; Wang Y Brain Res; 2001 Jan; 889(1-2):200-7. PubMed ID: 11166704 [TBL] [Abstract][Full Text] [Related]
11. Experimental hemiparkinsonism in the rat following chronic unilateral infusion of MPP+ into the nigrostriatal dopamine pathway--III. Reversal by embryonic nigral dopamine grafts. Sirinathsinghji DJ; Dunnett SB; Northrop AJ; Morris BJ Neuroscience; 1990; 37(3):757-66. PubMed ID: 2247221 [TBL] [Abstract][Full Text] [Related]
12. Improved graft survival and striatal reinnervation by microtransplantation of fetal nigral cell suspensions in the rat Parkinson model. Nikkhah G; Cunningham MG; Jödicke A; Knappe U; Björklund A Brain Res; 1994 Jan; 633(1-2):133-43. PubMed ID: 7907929 [TBL] [Abstract][Full Text] [Related]
13. Dopaminergic grafts implanted into the neonatal or adult striatum: comparative effects on rotation and paw reaching deficits induced by subsequent unilateral nigrostriatal lesions in adulthood. Abrous DN; Torres EM; Dunnett SB Neuroscience; 1993 Jun; 54(3):657-68. PubMed ID: 8332254 [TBL] [Abstract][Full Text] [Related]
14. Dopaminergic transplants suppress L-DOPA-induced Fos expression in the dopamine-depleted striatum in a rat model of Parkinson's disease. Ishida Y; Kuwahara I; Todaka K; Hashiguchi H; Nishimori T; Mitsuyama Y Brain Res; 1996 Jul; 727(1-2):205-11. PubMed ID: 8842399 [TBL] [Abstract][Full Text] [Related]
15. Mesencephalic grafts partially restore normal nigral dynorphin levels in 6-hydroxydopamine-lesioned rats treated chronically with L-dihydroxyphenylalanine. Roy E; Côté PY; Grégoire L; Parent A; Bédard PJ Neuroscience; 1995 May; 66(2):413-25. PubMed ID: 7477882 [TBL] [Abstract][Full Text] [Related]
16. Dose-dependent lesions of the dopaminergic nigrostriatal pathway induced by intrastriatal injection of 6-hydroxydopamine. Przedborski S; Levivier M; Jiang H; Ferreira M; Jackson-Lewis V; Donaldson D; Togasaki DM Neuroscience; 1995 Aug; 67(3):631-47. PubMed ID: 7675192 [TBL] [Abstract][Full Text] [Related]
17. A fetal nigral graft prevents behavioral supersensitivity associated with repeated injections of L-dopa in 6-OHDA rats. Correlation with D1 and D2 receptors. Rioux L; Gagnon C; Gaudin DP; Di Paolo T; Bédard PJ Neuroscience; 1993 Sep; 56(1):45-51. PubMed ID: 8232916 [TBL] [Abstract][Full Text] [Related]
18. Chronic treatment with levodopa and/or selegiline does not affect behavioral recovery induced by fetal ventral mesencephalic grafts in unilaterally 6-hydroxydopamine-lesioned rats. Adams CE; Hoffman AF; Hudson JL; Hoffer BJ; Boyson SJ Exp Neurol; 1994 Dec; 130(2):261-8. PubMed ID: 7867755 [TBL] [Abstract][Full Text] [Related]
19. Chronic intranigral administration of brain-derived neurotrophic factor produces striatal dopaminergic hypofunction in unlesioned adult rats and fails to attenuate the decline of striatal dopaminergic function following medial forebrain bundle transection. Lapchak PA; Beck KD; Araujo DM; Irwin I; Langston JW; Hefti F Neuroscience; 1993 Apr; 53(3):639-50. PubMed ID: 8098137 [TBL] [Abstract][Full Text] [Related]
20. Comparison between normal developing striatum and developing striatal grafts using drug-induced Fos expression and neuron-specific enolase immunohistochemistry. Labandeira-Garcia JL; Tobio JP; Guerra MJ Neuroscience; 1994 May; 60(2):399-415. PubMed ID: 7915411 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]